India is significantly boosting the use of domestic coal at power plants previously reliant on imports, aiming to slash costly overseas pur...

Investors are increasingly backing India's beauty and personal care manufacturing sector, moving beyond consumer brands. Companies like Nat...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Chinese investments and technology are welcome in India, but a cautious approach is needed for trade, according to CII President R Mukundan...

Delhivery has launched 'Abhyam', a comprehensive welfare program for its 1 lakh frontline workers. This initiative offers significant benef...

A gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...

Investors seeking relatively safe debt options for near-term or three-year-plus goals can consider corporate bond funds in June 2026. These...

Many working Indians face the unspoken challenge of funding elderly parents' care without jeopardizing their own financial future. With ris...

ET’s roundup of the wackiest whispers in corporate corridors.

ET Most Innovative AI Product Awards 2026 acknowledges AI products that are altering the medical field with faster, smarter and improved di...

India's beauty and personal care market is set for a significant surge, projected to hit $39 billion by 2030. Flipkart's report reveals a s...

Vetic, a pet care startup, has secured $40 million in funding. This investment will fuel the expansion of its clinic network, adding 25 new...

Bengaluru leads India in pet pampering, with most spending on treats and premium items. Cat food demand is high, making Mumbai the cat capi...

India is emerging as one of the most AI-ready healthcare markets in the Asia-Pacific region, with a growing number of consumers using gener...

The Ministry of External Affairs (MEA) on June 11 reiterated India's commitment to strengthening Afghanistan's healthcare system, announcin...

Novartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...